Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia
Condition(s) studied
Investigational drug(s) / intervention(s)
hypoxic induced factors: hypoxic induced factors analyzed in blood sample
Study summary
Patients with hereditary hemorrhagic telangiectasia (HHT) suffer from an inherited disorder leading to systemic vascular malformations. Mutations in several genes of the transforming growth factor (TGF)-β superfamily pathway influence angiogenesis in patients with HHT. The genetic loss of ALK1 or ENG alone are not sufficient to induce AVMs; environmental insults that could trigger angiogenesis (e.g. wounding) are also needed. In this study it will be analyzed if hypoxic induced factors could have an influence on the disease HHT.
Eligibility
Primary outcome measure(s)
- Differences in hypoxic induced factors — 12 months
Differences in hypoxic induced factors analyzed in blood samples from patients with HHT and healthy controls
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| University Hospital Essen | Essen | North Rhine-Westphalia | Recruiting |
More University Hospital, Essen trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04469517 on ClinicalTrials.gov ↗ ← All trials in Germany